-
Owen Mumford to debut insulin injection guide
Owen Mumford is releasing an insulin injection guide to better assist healthcare professionals in educating patients on healthy injection routines. Called “Injecting with Insulin: A Guide to Good Injection Technique,” the guide will be offered in both digital and print formats as early as this month.
(To view the full Home Health Care Report, click here.)
-
FDA approves 72 mcg dose of Linzess for chronic idiopathic constipation
CAMBRIDGE, Mass., and DUBLIN — The U.S. Food and Drug Administration approved Allergan and Ironwood Pharmaceutical’s Linzess (linaclotide) 72 mcg dose for the treatment of chronic idiopathic constipation in adult patients. The newly approved does is expected to available in the first quarter of this year.
Linzess is now FDA-approved in three dosage strengths: 290 mcg for adult patients with irritable bowel syndrome with constipation (IBS-C), and 145 mcg and a new 72 mcg for the treatment of adults with CIC.